Stock Report

Download full stock data and analysis for free Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

EVOQ Remedies Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 543500

₹1.62

₹0.00 (0.00%)

As on 03-Sep-2026 14:54IST

Market cap

info icon

₹4 Cr

Revenue (TTM)

info icon

₹12 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 190.11 -11.19 5.32
EBIT -- -- -38.99 -216.05 -604.44
Net Profit -- -- -80.50 -56.76 211.65
EPS -- -- -89.36 -64.67 --
Book Value -- -- -3.62 1.64 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info -26.12-12.03-19.45-40.59-18.33
Net Margin info 4.644.640.627.176.13
Return on equity info 2.9440.970.251.816.75
Return on Capital info 3.0753.050.351.926.96
Return on Assets info 2.074.390.201.264.75
Debt to Equity (x) info ----0.000.170.39

Profitability

View Detailed Peer Comparison

ROCE

0.35

Lower than Peers by 21.42

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.35
1.92
6.96
9.12
246.90
Peer Median
21.76
21.89
--
17.36
20.68
ROE

0.25

Lower than Peers by 17.68

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.25
1.81
6.75
9.13
186.89
Peer Median
17.93
16.42
--
17.35
18.46
ROA

0.20

Lower than Peers by 12.61

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.20
1.26
4.75
5.27
10.45
Peer Median
12.81
12.32
--
10.65
9.97
EBIT Margin

-19.45

Lower than Peers by 38.38

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
-19.45
-40.59
-18.33
8.72
9.52
Peer Median
18.93
21.05
--
11.27
13.36
Net Margin

0.62

Lower than Peers by 14.32

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.62
7.17
6.13
6.50
7.14
Peer Median
14.94
15.51
--
11.45
10.42
Cash Profit Margin

1.17

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
1.17
11.34
7.96
6.50
7.14
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

190.11

Higher than Peers by 179.21

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
190.11
-80.13
21.49
67.42
10.50
Peer Median
10.90
13.44
--
11.49
33.32
EBIT Growth

-38.99

Lower than Peers by 54.00

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
-38.99
55.98
-355.43
53.34
1,36,201.70
Peer Median
15.01
23.50
--
-1.10
80.05
Net Profit Growth

-80.50

Lower than Peers by 95.30

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
-80.50
-72.06
48.38
52.53
--
Peer Median
14.80
30.12
--
4.90
98.25
EPS Growth

-89.36

Lower than Peers by 103.62

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
-89.36
-72.07
48.39
-92.04
--
Peer Median
14.27
29.02
--
10.00
98.25
Book Value Growth

76.47

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
76.47
1.82
6.99
3,017.87
3,187.69
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
--
0.17
0.39
0.35
0.00
Peer Median
0.06
0.03
--
0.18
0.23
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
--
0.17
0.39
0.35
--
Peer Median
--
--
--
--
--
Current Ratio

9.10

Higher than Peers by 7.19

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
9.10
3.17
3.45
3.28
1.10
Peer Median
1.90
2.23
--
1.72
1.68
Quick Ratio

8.69

Higher than Peers by 7.23

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
8.69
2.90
3.25
3.20
1.08
Peer Median
1.46
1.59
--
1.41
1.62
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
--
6,115.00
1,758.31
318.04
5,225.15
Peer Median
24.96
45.29
--
24.64
8.93

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

73.29

Higher than Peers by 51.52

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
73.29
43.00
84.43
151.33
68.19
Peer Median
21.77
20.10
--
23.77
21.01
Asset Turnover

0.27

Lower than Peers by 0.49

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.27
0.11
0.60
0.81
1.46
Peer Median
0.76
0.81
--
1.05
0.99
Receivable days

160.81

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
160.81
853.76
381.41
350.51
210.34
Peer Median
--
--
--
--
--
Inventory Days

82.96

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
82.96
232.24
25.21
10.17
3.85
Peer Median
--
--
--
--
--
Payable days

94.59

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
94.59
321.89
6.35
105.88
288.30
Peer Median
--
--
--
--
--
Cash Conversion Cycle

149.18

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
149.18
764.12
400.27
254.80
-74.11
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

72.32

Higher than Peers by 45.51

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
72.32
26.07
10.91
28.17
--
Peer Median
26.81
39.85
--
26.65
30.53
Price / Book Value

0.14

Lower than Peers by 4.51

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
0.14
0.47
0.71
1.33
--
Peer Median
4.65
6.11
--
3.55
5.29
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
--
--
--
--
--
Peer Median
0.61
0.37
--
0.04
--
EV/EBITDA

34.78

Higher than Peers by 7.77

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
34.78
25.70
11.83
24.47
-0.02
Peer Median
27.02
34.57
--
17.31
26.90
Market Cap

6

Lower than Peers by 20,908

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EVOQ Remedies
6
12
18
31
--
Peer Median
20,914
25,297
--
474
550
loading...
loading...
loading...